Jelena Klawitter
Papers
1
Total Citations
49
H-Index
1
About
Jelena Klawitter is a leading researcher in clinical pharmacology and bioanalytical chemistry, with a primary focus on the pharmacokinetics and metabolism of immunosuppressive drugs. Her most cited work, a 2011 study detailing a high-throughput U-HPLC–MS/MS assay for quantifying mycophenolic acid (MPA) and its major metabolites in human plasma and urine, has garnered 49 citations, underscoring its critical role in advancing therapeutic drug monitoring. This method enables precise, simultaneous measurement of MPA and its glucuronide conjugates, including the toxic acyl-glucuronide, facilitating safer and more effective immunosuppressive therapy in transplant patients. Klawitter’s contributions extend to elucidating drug metabolism pathways and developing robust analytical tools that bridge bench research and clinical application. Her work is instrumental for researchers and clinicians aiming to optimize dosing regimens and minimize adverse effects. By providing reliable, high-throughput assays, she has significantly impacted the field of personalized medicine, making her a key figure in improving outcomes for patients undergoing organ transplantation.
Research Focus
Key Achievements
Top Papers
- 1